CHDR investigating the effects of EPO on cycling performance

Описание: A randomized, double-blind, placebo-controlled study to investigate the effects of recombinant human erythropoietin (NeoRecormon) on cycling performance and the occurrence of adverse events in well-trained cyclists.

The research has been published in Lancet Hematology Journal, see https://chdr.nl/news/the-lancet-haema...